02.27.23 -- Are We Doing Enough To Reduce Participant Burden In Trials?

The short answer: No. Asked whether industry is doing enough to accommodate patients enrolled in clinical trials, Walgreens’ head of decentralized clinical trials, John Campbell, and CVS’s health senior VP of clinical trial services, Tony Clapsis, discuss the current state of patient burden and opportunities for improvement.

Establishing true and valuable collaborations with patients can be very simple and has so much value: why still hesitate? Watch to learn more.

Learn how Medidata is offering sponsors and CROs access to the award-winning Patient Centricity by Design process to help guide the creation of protocols and patient-facing solutions to improve clinical trial experiences.

It is well known that certain ethnic groups are routinely underrepresented in global clinical trials. But another data set now shows that some of those ethnic groups are also disproportionately consuming pharmaceuticals. Vladimir Misik, of VIARES Academy, explores why that is — and how to rectify it.

Diversity has taken center stage in the clinical trial industry and many organizations are looking to make a difference in this arena. Gain insight into some of the key learnings from a recent event that addressed diversity, equity, and inclusion in the drug development life cycle.

Learn why improving representation in clinical trials is a long-standing and difficult challenge, and read about several key recommendations from an experienced research clinician that can help solve representation challenges to make sure no one is left behind.

In this webinar, Amanda Ryan, president of G3 Life Sciences, will speak with Aman Khera, VP, global head of regulatory strategy at Worldwide Clinical Trials, and Luke Gelinas, Advarra’s IRB chair and senior advisor, about their perspectives on diversity in clinical trials.

As the industry faces unprecedented macroeconomic issues, including substantial staffing challenges and inflationary pressures, resources are desperately needed to support clinical research sites and studies. As a sponsor company, consider ways to help sites right now: Can existing budgets be adjusted? If not, what other solutions may be available? 

Whether to ensure GCP compliance or the correct application of a study protocol, training is a critical part of any clinical trial. Find out why.